18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

A 0 1 25 26 O
confirmed 2 11 27 36 O
tumor 12 17 37 42 B-cancer
site 18 22 43 47 O
is 23 25 48 50 O
one 26 29 51 54 O
in 30 32 55 57 O
which 33 38 58 63 O
is 39 41 64 66 O
biopsy 42 48 67 73 B-treatment
- 48 49 73 74 O
proven 49 55 74 80 O

Patients 0 8 81 89 O
must 9 13 90 94 O
agree 14 19 95 100 B-contraception_consent
to 20 22 101 103 I-contraception_consent
use 23 26 104 107 I-contraception_consent
a 27 28 108 109 I-contraception_consent
medically 29 38 110 119 I-contraception_consent
effective 39 48 120 129 I-contraception_consent
method 49 55 130 136 I-contraception_consent
of 56 58 137 139 I-contraception_consent
contraception 59 72 140 153 I-contraception_consent
during 73 79 154 160 O
and 80 83 161 164 O
for 84 87 165 168 O
a 88 89 169 170 O
period 90 96 171 177 O
of 97 99 178 180 O
three 100 105 181 186 B-upper_bound
months 106 112 187 193 I-upper_bound
after 113 118 194 199 O
the 119 122 200 203 O
treatment 123 132 204 213 B-treatment
period 133 139 214 220 O

Patients 0 8 221 229 O
must 9 13 230 234 O
have 14 18 235 239 O
a 19 20 240 241 O
Karnofsky 21 30 242 251 B-clinical_variable
performance 31 42 252 263 I-clinical_variable
status 43 49 264 270 I-clinical_variable
70 50 52 271 273 O
% 52 53 273 274 O

Patients 0 8 275 283 O
must 9 13 284 288 O
have 14 18 289 293 O
at 19 21 294 296 O
least 22 27 297 302 O
one 28 31 303 306 O
confirmed 32 41 307 316 O
and 42 45 317 320 O
evaluable 46 55 321 330 O
tumor 56 61 331 336 B-cancer
site 62 66 337 341 O

Patients 0 8 342 350 O
with 9 13 351 355 O
a 14 15 356 357 O
documented 16 26 358 368 O
histologic 27 37 369 379 O
diagnosis 38 47 380 389 O
of 48 50 390 392 O
relapsed 51 59 393 401 O
or 60 62 402 404 O
refractory 63 73 405 415 O
glioblastoma 74 86 416 428 B-cancer
multiforme 87 97 429 439 I-cancer
( 98 99 440 441 I-cancer
GBM 99 102 441 444 I-cancer
) 102 103 444 445 I-cancer
, 103 104 445 446 O
anaplastic 105 115 447 457 B-cancer
astrocytoma 116 127 458 469 I-cancer
( 128 129 470 471 I-cancer
AA 129 131 471 473 I-cancer
) 131 132 473 474 I-cancer
or 133 135 475 477 O
anaplastic 136 146 478 488 B-cancer
mixed 147 152 489 494 I-cancer
oligoastrocytoma 153 169 495 511 I-cancer
( 170 171 512 513 I-cancer
AOA 171 174 513 516 I-cancer
) 174 175 516 517 I-cancer

Patients 0 8 518 526 O
with 9 13 527 531 O
significant 14 25 532 543 O
inter 26 31 544 549 O
- 31 32 549 550 O
current 32 39 550 557 O
medical 40 47 558 565 B-chronic_disease
or 48 50 566 568 I-chronic_disease
psychiatric 51 62 569 580 I-chronic_disease
conditions 63 73 581 591 I-chronic_disease
that 74 78 592 596 O
would 79 84 597 602 O
place 85 90 603 608 O
them 91 95 609 613 O
at 96 98 614 616 O
increased 99 108 617 626 O
risk 109 113 627 631 O
or 114 116 632 634 O
affect 117 123 635 641 O
their 124 129 642 647 O
ability 130 137 648 655 O
to 138 140 656 658 O
receive 141 148 659 666 O
or 149 151 667 669 O
comply 152 158 670 676 O
with 159 163 677 681 O
treatment 164 173 682 691 O
or 174 176 692 694 O
post 177 181 695 699 O
- 181 182 699 700 O
treatment 182 191 700 709 O
clinical 192 200 710 718 O
monitoring 201 211 719 729 O

Previous 0 8 730 738 O
treatment 9 18 739 748 B-treatment
with 19 23 749 753 O
greater 24 31 754 761 O
than 32 36 762 766 O
2 37 38 767 768 B-lower_bound
cycles 39 45 769 775 O
of 46 48 776 778 O
Bevacizumab 49 60 779 790 B-treatment
at 61 63 791 793 O
10mg 64 68 794 798 O
/ 68 69 798 799 O
kg 69 71 799 801 O
( 72 73 802 803 O
2 73 74 803 804 O
IV 75 77 805 807 O
Infusions 78 87 808 817 O
) 87 88 817 818 O

Women 0 5 819 824 B-gender
who 6 9 825 828 O
are 10 13 829 832 O
pregnant 14 22 833 841 B-pregnancy

equivalent 0 10 842 852 O
ECOG 11 15 853 857 B-clinical_variable
level 16 21 858 863 I-clinical_variable
of 22 24 864 866 O
0 25 26 867 868 B-lower_bound
- 26 27 868 869 O
2 27 28 869 870 B-upper_bound

